The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, F. A.
Right arrow Articles by Bankert, R. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, F. A.
Right arrow Articles by Bankert, R. B.

The Journal of Immunology, Vol 155, Issue 6 2833-2840, Copyright © 1995 by American Association of Immunologists


ARTICLES

Human antibody response in human peripheral blood leukocyte/severe combined immunodeficient chimeric model is dependent on B and T cell costimulation via CD40/CD40 ligand

FA Chen, SS Williams, WC Fanslow and RB Bankert
Department of Molecular Immunology, Roswell Park Cancer Institute, Buffalo, NY 14263, USA.

We have used a human/severe combined immunodeficient (SCID) mouse chimeric model (in which human PBLs are engrafted into SCID mice) to investigate in vivo the role of the CD40/CD40 ligand (CD40L) interaction in the generation of humoral immunity by engrafted human cells. It is established in this work that the thymic dependent, multiclonal, humoral immune response of human lymphocytes to mouse erythrocyte protein Ags is inhibited significantly when CD40/CD40L ligation is prevented in vivo. Suppression of the response was observed with administration of neutralizing Abs specific for either CD40 or CD40L, or with the soluble fusion protein human CD40-Fc. Human anti- mouse erythrocyte Abs and the total human Ig levels in the sera of the SCID mice were suppressed for up to 10 wk when the neutralizing agents were administered at the time of human leukocyte engraftment, i.e., coincident with Ag stimulation, and subsequently at 2 and 4 days after Ag stimulation. These results are the first to demonstrate the ability of CD40/CD40L blocking agents to inhibit the human Ag-specific humoral immune response in vivo, and they sustain the notion that these blocking agents may be utilized clinically to eliminate immune responses associated with autoimmunity or allergy. In addition to confirming the importance of the CD40/CD40L interaction of T and B cells in vivo, it is established in this work that the mouse erythrocyte-specific humoral immune response of the lymphocytes in the human PBL/SCID mouse model is a bona fide T cell-dependent response, and that this is a viable model with which to study human lymphocyte activation in vivo. These results also suggest that the costimulatory activation of human B and T cells is not dependent on the microenvironment of the germinal centers.


This article has been cited by other articles:


Home page
J. Immunol.Home page
M. R. Simpson-Abelson, G. F. Sonnenberg, H. Takita, S. J. Yokota, T. F. Conway Jr., R. J. Kelleher Jr., L. D. Shultz, M. Barcos, and R. B. Bankert
Long-Term Engraftment and Expansion of Tumor-Derived Memory T Cells Following the Implantation of Non-Disrupted Pieces of Human Lung Tumor into NOD-scid IL2R{gamma}null Mice
J. Immunol., May 15, 2008; 180(10): 7009 - 7018.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Kuwana, S. Nomura, K. Fujimura, T. Nagasawa, Y. Muto, Y. Kurata, S. Tanaka, and Y. Ikeda
Effect of a single injection of humanized anti-CD154 monoclonal antibody on the platelet-specific autoimmune response in patients with immune thrombocytopenic purpura
Blood, February 15, 2004; 103(4): 1229 - 1236.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Depraetere, L. Verhoye, G. Leclercq, and G. Leroux-Roels
Human B Cell Growth and Differentiation in the Spleen of Immunodeficient Mice
J. Immunol., March 1, 2001; 166(5): 2929 - 2936.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. S. Evans, D. M. Schleider, L. A. Bowman, M. L. Francis, G. S. Kansas, and J. D. Black
Dynamic Association of L-Selectin with the Lymphocyte Cytoskeletal Matrix
J. Immunol., March 15, 1999; 162(6): 3615 - 3624.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. A. Coccia and P. Brams
High Titer, Prostate Specific Antigen-Specific Human IgG Production by hu-PBL-SCID Mice Immunized with Antigen-Mouse IgG2a Complex-Pulsed Autologous Dendritic Cells
J. Immunol., November 15, 1998; 161(10): 5772 - 5780.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. Delhem, F. Hadida, G. Gorochov, F. Carpentier, J.-P. de Cavel, J.-F. Andreani, B. Autran, and J.-Y. Cesbron
Primary Th1 Cell Immunization Against HIVgp160 in SCID-hu Mice Coengrafted with Peripheral Blood Lymphocytes and Skin
J. Immunol., August 15, 1998; 161(4): 2060 - 2069.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. Brams, M.-L. Nguyen, S. Chamat, I. Royston, and P. R. Morrow
Antigen-Specific IgG Responses from Naive Human Splenocytes: In Vitro Priming Followed by Antigen Boost in the SCID Mouse
J. Immunol., March 1, 1998; 160(5): 2051 - 2058.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1995 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1995 by The American Association of Immunologists, Inc. All rights reserved.